Brief: Portage Biotech Provides Update On Clinical-Stage, Development Programs
31/03/2022 13:46
March 31 (Reuters) - Portage Biotech Inc PRTG.O :
* PORTAGE BIOTECH PROVIDES UPDATE ON CLINICAL-STAGE AND
DEVELOPMENT PROGRAMS
* PORTAGE BIOTECH INC - COMPANY CONTINUES TO WORK TOWARD
MULTIPLE
CLINICAL READOUTS IN 2022
* PORTAGE BIOTECH INC - FUNDED TO LEVERAGE OUR PRODUCT
ENGINE TO
DELIVER ON IMPORTANT CLINICAL MILESTONES THROUGH END OF 2023
Source text for Eikon: ID:nGNXb1Vwy4
Further company coverage: PRTG.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Alpha Compute
See all newsBrief: Alpha Compute Corp. Provides Mid-Q2 2026 Update
Brief: Alpha Compute Ai Gpu Launch Update First Large-Scale Nvidia Blackwell Cluster
Brief: Alpha Compute Appoints Tom Richer To Advisory Board To Accelerate Ai Gpu Compute Infrastructure And Confidential Cloud Strategy
Brief: Alphaton Capital Rebrands As Alpha Compute Corp. To Reflect Its Growing Ai Compute Business
Brief: Alphaton Capital Announces $43 Million Ai Infrastructure And Financing Partnership With Vertical Data